Cacti Asset Management Lifted By $7.45 Million Its Cvs Caremark (CVS) Position; Parametric Portfolio Associates Has Lowered Blucora (BCOR) Holding

Parametric Portfolio Associates Llc decreased Blucora Inc (BCOR) stake by 21.48% reported in 2017Q3 SEC filing. Parametric Portfolio Associates Llc sold 41,484 shares as Blucora Inc (BCOR)’s stock rose 29.25%. The Parametric Portfolio Associates Llc holds 151,634 shares with $3.84 million value, down from 193,118 last quarter. Blucora Inc now has $1.16 billion valuation. The stock increased 1.74% or $0.43 during the last trading session, reaching $24.85. About 198,519 shares traded. Blucora, Inc. (NASDAQ:BCOR) has risen 147.59% since March 11, 2017 and is uptrending. It has outperformed by 130.89% the S&P500.

Cacti Asset Management Llc increased Cvs Caremark Corporation (CVS) stake by 19% reported in 2017Q3 SEC filing. Cacti Asset Management Llc acquired 92,005 shares as Cvs Caremark Corporation (CVS)’s stock declined 4.23%. The Cacti Asset Management Llc holds 576,253 shares with $46.86 million value, up from 484,248 last quarter. Cvs Caremark Corporation now has $70.27 billion valuation. The stock increased 1.33% or $0.91 during the last trading session, reaching $69.27. About 5.80M shares traded. CVS Health Corporation (NYSE:CVS) has declined 24.40% since March 11, 2017 and is downtrending. It has underperformed by 41.10% the S&P500.

Parametric Portfolio Associates Llc increased Lowe’s Cos Inc (NYSE:LOW) stake by 410,085 shares to 3.89M valued at $311.13M in 2017Q3. It also upped Suez Enviornnement Sa (SZEVY) stake by 86,379 shares and now owns 1.10M shares. Stora Enso Corp Spon Adr Rep R (SEOAY) was raised too.

Among 4 analysts covering Blucora (NASDAQ:BCOR), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Blucora has $2300 highest and $10 lowest target. $16.33’s average target is -34.29% below currents $24.85 stock price. Blucora had 9 analyst reports since August 22, 2015 according to SRatingsIntel. Wedbush maintained the shares of BCOR in report on Friday, February 12 with “Outperform” rating. The firm has “Buy” rating given on Saturday, August 22 by Benchmark. The firm has “Buy” rating given on Monday, August 24 by Benchmark. On Wednesday, July 26 the stock rating was maintained by Benchmark with “Buy”. Barrington Research upgraded it to “Outperform” rating and $10 target in Monday, May 2 report. The stock of Blucora, Inc. (NASDAQ:BCOR) earned “Buy” rating by Benchmark on Tuesday, February 16. On Friday, October 28 the stock rating was maintained by Barrington Research with “Outperform”. Craig Hallum upgraded the shares of BCOR in report on Friday, April 29 to “Buy” rating.

Investors sentiment decreased to 0.72 in 2017 Q3. Its down 0.16, from 0.88 in 2017Q2. It dived, as 60 investors sold CVS shares while 571 reduced holdings. 88 funds opened positions while 466 raised stakes. 801.45 million shares or 0.31% less from 803.96 million shares in 2017Q2 were reported. Veritas Asset Ltd Liability Partnership accumulated 8.67M shares. 4,179 were accumulated by Papp L Roy & Associates. 19,741 are held by Cap City Com Fl. Ontario Teachers Pension Plan Board accumulated 761,602 shares. Telos Management invested 0.95% in CVS Health Corporation (NYSE:CVS). Northstar invested in 3,366 shares or 0.05% of the stock. Hsbc Hldgs Public Ltd Limited Liability Company invested 0.14% in CVS Health Corporation (NYSE:CVS). 2,576 were reported by Wealthtrust. Credit Agricole S A has invested 0.41% in CVS Health Corporation (NYSE:CVS). Cornerstone owns 0.08% invested in CVS Health Corporation (NYSE:CVS) for 1,439 shares. Capwealth Advsrs Ltd has invested 0.07% in CVS Health Corporation (NYSE:CVS). Factory Mutual holds 1.23% in CVS Health Corporation (NYSE:CVS) or 1.38M shares. Endurant Capital Mgmt LP accumulated 0.68% or 27,500 shares. Bridgeway Capital Inc holds 620,765 shares or 0.58% of its portfolio. Massachusetts-based Seaward Mngmt Partnership has invested 0.51% in CVS Health Corporation (NYSE:CVS).